Hearing Characteristics of Adults before Exposure to Potentially Ototoxic Chemotherapy. [PDF]
Peruch CV +5 more
europepmc +1 more source
Rediscovering the Gut-Mito-Ear Axis: A Systems-Biology Framework for Ototoxic Vulnerability and Microbiome-Targeted Prevention. [PDF]
Yim CD +6 more
europepmc +1 more source
Targeting ferroptosis in sensorineural hearing loss: mechanisms, therapeutics, and translational prospects. [PDF]
Zhang L, Luo P, Liu X, Guo T, Xie H.
europepmc +1 more source
From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. [PDF]
Iațentiuc A +11 more
europepmc +1 more source
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study. [PDF]
Sanchez VA +19 more
europepmc +1 more source
Delayed Complete Spontaneous Hearing Recovery in a Pediatric Chemotherapy Patient-A Case Report. [PDF]
Bentan MA +3 more
europepmc +1 more source
Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]
Hecker DJ +11 more
europepmc +1 more source
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience. [PDF]
Sousa LG +22 more
europepmc +1 more source
In Silico Hazard Assessment of Ototoxicants Through Machine Learning and Computational Systems Biology. [PDF]
Luan S, Ji C, Zarus GM, Reh CM, Ruiz P.
europepmc +1 more source
Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]
Peláez Casillas N +4 more
europepmc +1 more source

